Truist Securities Maintains Hold on Organogenesis Holdings, Lowers Price Target to $2

Benzinga · 1d ago
Truist Securities analyst Ravi Misra maintains Organogenesis Holdings (NASDAQ:ORGO) with a Hold and lowers the price target from $3 to $2.